SHShokoufeh Hajsadeghi

Shokoufeh Hajsadeghi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Shokoufeh Hajsadeghi has a total of 5 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

    • 13 January 2016
      • Vol. 11  (1) , 11-14
    Open Access

    Left Ventricular Mass Index and Pulmonary Artery Pressure in Patients with the Obstructive Sleep Apnea Syndrome

    by Seyed Hashem Sezavar, Shokoufeh Hajsadeghi, Maral Hejrati, Mir Farhad Ghaleh Bandi

    Background: Sleep apnea is accompanied by some cardiovascular complications. It has even been hypothesized that sleep apnea, itself, can induce some of these complications. Given such controversies, we assessed the left ventricular mass index (LVMI) and systolic pulmonary artery pressure in patients with sleep apnea.


    • 8 January 2015
      • Vol. 10  (1) , 46-49
    Open Access

    Right Ventricular Thrombus in a 36-Year-Old Man with Factor V Leiden

    by Shokoufeh Hajsadeghi, Roozbeh Naghshin, Maral Hejrati, Scott Reza Jafarian Kerman

    Factor V Leiden deficiency is the most common hereditary hypercoagulable disease in the United States and involves 5% of the Caucasian population. Up to 30% of patients who present with deep vein thrombosis (DVT) or pulmonary thromboembolism present with this condition. This is a case report of a 36-year-old man who experienced one episode of DVT within the previous year and was admitted to our hospital due to productive coughs and hemoptysis. Paraclinical studies demonstrated a right ventricular thrombus. Additional investigation was done to find the underlying cause. Laboratory tests were positive for Factor V Leiden mutation. Other factors for hypercoagulability states were normal. Given that Factor V Leiden mutation is a life-threatening condition with a relatively high prevalence and considering its thrombogenesis, screening tests are necessary in young patients without obvious reasons for recurrent thrombus formation. It seems that medical noninvasive treatments can be an alternative therapy to surgery when a ventricular thrombus is suspected in these patients.